Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 8Genitourinary 7Breast 6Tumor-Agnostic 2Thoracic 2Lymphoid 2Other hematologic neoplasm 1Head & Neck 1Gynecologic 1Endocrine 1CNS 1

Conditions

Lung Neoplasms 2

Interventions

Blood Specimen Collection 44Radiosurgery 41Early Intervention, Educational 33Standard of Care 31Exercise 30Educational Status 30Methods 28Drug Therapy 26Radiotherapy 23Magnetic Resonance Spectroscopy 23Surveys and Questionnaires 21Practice Guidelines as Topic 21X-Rays 17Pemetrexed 17Carboplatin 16Biopsy 16Tomography, X-Ray Computed 14Thoracic Surgery, Video-Assisted 14Therapeutics 12Fluorodeoxyglucose F18 12Interviews as Topic 11Gefitinib 11Cisplatin 11Specimen Handling 10Patient Navigation 10Cryosurgery 10anlotinib 9Surgical Procedures, Operative 9Psychiatric Rehabilitation 9Palliative Care 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × High-Intensity Interval Training × Thoracic × Clear all
NCT06026111 2026-04-14

ENHANCE

Dana-Farber Cancer Institute

Phase NA Recruiting
30 enrolled
Thoracic

Lung Neoplasms

NCT06215326 2024-03-01

PRE-EXELUCA

Guangdong Provincial People's Hospital

Phase NA Recruiting
100 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡